Literature DB >> 4566289

Hepatitis with Australia antigenemia following renal transplantation.

A Aronoff, M H Gault, S N Huang, S Lal, K T Wu, M D Moinuddin, L Spence, L D MacLean.   

Abstract

Over a seven-year period 18 of 125 patients who underwent renal transplantation developed hepatitis. Acute hepatic necrosis occurred in two, chronic aggressive hepatitis progressing to posthepatitic cirrhosis in eight, chronic persistent hepatitis in five, acute hepatitis with recovery in two and cholestatic hepatitis in one. Hepatic failure was the cause of death in four and a major contributing factor in three. Fifteen of the 18 were of blood Group A. After renal transplantation Australia antigen (Au) was present in the blood of 12 of the 15 patients with hepatitis who were tested and in one of 38 patients without clinical evidence of liver disease. Once present, Au persisted in all patients but one. Particles measuring 210 to 250 A, characteristic of Au, were seen in liver cells by electronmicroscopy in nine of the 10 patients examined who had hepatitis with Australia antigenemia, but they were not seen in the two patients studied with Au-negative hepatitis.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4566289      PMCID: PMC1941116     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  24 in total

1.  Clinically evident, non-terminal infections with herpesviruses and the wart virus in immunosuppressed renal allograft recipients.

Authors:  E S Spencer; H K Andersen
Journal:  Br Med J       Date:  1970-08-01

2.  The period and nature of hazard in clinical renal transplantation. I. The hazard to patient survival.

Authors:  T C Moore; D M Hume
Journal:  Ann Surg       Date:  1969-07       Impact factor: 12.969

3.  An epidemic of hepatitis in a chronic-hemodialysis unit. Australia antigen and differences in host response.

Authors:  W T London; M Di Figlia; A Sutnick; B S Blumberg
Journal:  N Engl J Med       Date:  1969-09-11       Impact factor: 91.245

4.  Cadaver kidney transplants.

Authors:  J B Dossetor; K J MacKinnon; M H Gault; L D MacLean
Journal:  Transplantation       Date:  1967-07       Impact factor: 4.939

5.  Hepatitis in hemodialysis units.

Authors:  C E Huggins
Journal:  N Engl J Med       Date:  1970-09-17       Impact factor: 91.245

6.  Some factors regulating duration of incubation for serum hepatitis.

Authors:  J G Allen
Journal:  Arch Surg       Date:  1970-01

7.  Liver disease in patients treated with chronic hemodialysis.

Authors:  K J Ivey; J A Clifton
Journal:  Gastroenterology       Date:  1970-10       Impact factor: 22.682

8.  Dialysis-associated hepatitis: prevention and control.

Authors:  B J Hawe; H J Goldsmith; P O Jones
Journal:  Br Med J       Date:  1971-03-06

9.  Blood group distribution in patients with cirrhosis of the liver.

Authors:  L Ranek; E Juhl
Journal:  Scand J Gastroenterol Suppl       Date:  1970

10.  A complement-fixation test for measuring Australia antigen and antibody.

Authors:  R H Purcell; P V Holland; J H Walsh; D C Wong; A G Morrow; R M Chanock
Journal:  J Infect Dis       Date:  1969-09       Impact factor: 5.226

View more
  4 in total

1.  Virus infections after transplantation in man. Brief review.

Authors:  M Ho
Journal:  Arch Virol       Date:  1977       Impact factor: 2.574

2.  Jaundice after renal allotransplantation.

Authors:  M F Mozes; N L Ascher; H H Balfour; R L Simmons; J S Najarian
Journal:  Ann Surg       Date:  1978-12       Impact factor: 12.969

3.  Contrasting features and responses to treatment of severe chronic active liver disease with and without hepatitis BS antigen.

Authors:  S W Schalm; W H Summerskill; G L Gitnick; L R Elveback
Journal:  Gut       Date:  1976-10       Impact factor: 23.059

4.  Non-viral related liver enzymes elevation after kidney transplantation.

Authors:  Behzad Einollahi; Alireza Ghadian; Ebrahim Ghamar-Chehreh; Seyed Moayed Alavian
Journal:  Hepat Mon       Date:  2014-02-05       Impact factor: 0.660

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.